Clinical Trial

Developing Resiliency and Exercise Using AI-based Messaging

Study acronym: DREAM
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a randomized, controlled pilot trial to examine the feasibility, acceptability, and preliminary efficacy of the DREAM program, an 8-week message-based intervention to promote physical activity and well-being in adults with type 2 diabetes.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-04; most recent amendment 2026-05-15.
Trial Details
NCT Number NCT07225283
Lead Sponsor Massachusetts General Hospital
Conditions Diabetes Mellitus Type 2
Enrollment 20 participants
Start Date 2026-09-01
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-18